Associates for the Advancement of Musculoskeletal Innovation, Inc. – Trademark Portfolio
Entity Type: 03
Associates for the Advancement of Musculoskeletal Innovation, Inc. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include GODIRECT. The owner is based in Ponte Vedra Beach, FL.
822 N. A1A Highway, Suite 310
Ponte Vedra Beach, FL 32082
Showing of trademarks Trademarks
Trademark Classifications
Associates for the Advancement of Musculoskeletal Innovation, Inc.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Frequently Asked Questions
How many trademarks does Associates for the Advancement of Musculoskeletal Innovation, Inc. have?
Associates for the Advancement of Musculoskeletal Innovation, Inc. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Associates for the Advancement of Musculoskeletal Innovation, Inc. file in?
Associates for the Advancement of Musculoskeletal Innovation, Inc. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Associates for the Advancement of Musculoskeletal Innovation, Inc.'s most well-known trademarks?
Associates for the Advancement of Musculoskeletal Innovation, Inc.'s registered trademark portfolio includes well-known marks such as GODIRECT. These are among 1 currently registered trademark in the portfolio.
What is Associates for the Advancement of Musculoskeletal Innovation, Inc.'s trademark registration success rate?
Associates for the Advancement of Musculoskeletal Innovation, Inc. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.